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IntrODuctIOn
A therosclerosis is a complex inflammatory disease afflicting medium-and large-sized arteries and is the leading cause of death in the United States (Lethbridge-Cejku et al., 2004; Rosamond et al., 2008) . The fact that inflammation has a pivotal role in the development of atherosclerosis has intensified the search for chronic exposure to infectious organisms that have the potential to cause inflammation in vessels (Libby et al., 2002; Lucas et al., 2006) . One type of atherosclerosis, restenosis, results from rapid plaque growth after percutaneous intervention with balloon angioplasty (BA) (Jones et al., 2009 ). This surgery causes local endothelial cell damage. One can postulate that local bacterial infections induce inflammatory cell invasion and promote arterial injury in both native and BA-treated vessels.
Numerous studies have demonstrated the presence of genomic DNA from several oral bacteria, including S. mutans, in human atherosclerotic lesions (Kozarov et al., 2006; Nakano et al., 2006 Nakano et al., , 2009 . S. mutans is disseminated via bacteremia (Huang et al., 2008) and is also a causative agent of infective endocarditis (IE) (Nakano et al., 2007b) . Significantly, S. mutans was the most predominant bacterial species detected in diseased heart valves and atheromatous plaques, with detection rates of 63% and 74%, respectively. We have also previously reported that S. mutans was detected with high prevalence in atheromatous plaque in 22.5% of younger patients (~27 yrs of age) and in 44.4% of older patients (~67 yrs of age) (Kozarov et al., 2006) . In the Nakano et al. study, oral specimens from cardiovascular disease (CVD) patients were more complex, including multiple serotypes, and had far fewer serotype c isolates when compared with those from patients with no known CVD. These findings suggest that specific strains of S. mutans may play a role in the infection of cardiovascular tissues, and those individuals harboring these strains may be at higher risk for CVD (Nakano et al., 2007a,b) . co-workers (2009, 2011) examined 30 strains of S. mutans and found that some serotype e and f strains were capable of invading human coronary artery endothelial cells (HCAEC). Of these, a serotype f strain, OMZ175, was the most invasive, whereas strains of serotype c were not invasive. They have also reported that a collagen binding protein, Cnm, is required for invasion (Abranches et al., 2011) . However, the nature of in vivo interactions between S. mutans and cardiovascular cells and the role of invasive strains in the initiation and progression of atherosclerosis have not yet been investigated. The aim of this study was to examine the ability of S. mutans strain OMZ175 to infect and/or to accelerate atherogenesis in a pro-atherogenic mouse model. Effects of strain OMZ175 infection on plaque growth Increased Atherogenesis during Streptococcus mutans Infection in ApoE-null Mice J Dent Res 91 (3) 2012 were examined with and without BA-induced vascular injury (Lucas et al., 1996; Petrov et al., 2005) .
MAtErIAls & MEthODs bacterial strain and Microbial Inocula
S. mutans strain OMZ175 was used in this study and was cultured and maintained for infection of mice as described previously (Abranches et al., 2009) . The concentration of bacteria was determined quantitatively, and the organism was re-suspended in phosphate-buffered saline (pH 7.2) at 1 x 10 9 bacteria per mL.
Mice
Forty 10-week-old male ApoE -/mice (Strain B6.129P2-ApoE tm1Unc/J ) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) (Lucas et al., 1996; Li et al., 2002; Gibson et al., 2004) . After 1 wk of acclimatization, they were fed a high-fat diet (HFD) (Atherogenic diet Teklad, Harlan, Indianapolis, IN, USA) for 8 wks (Fig. 1A ). Mice were then randomized into 4 groups (Group I, S. mutans + BA; Group II, S. mutans alone; Group III, sham-infected with BA; and Group IV, sham-infected without BA). The control groups were shared with a complementary, but separate, study. All animal procedures were performed in accordance with policies of the Institutional Animal Care and Use Committee of the University of Florida.
Mouse Aortic Angioplasty Model
BA was performed on 2 groups of 13-week-old mice to induce endothelial cell injury in the aortas as previously described (Lucas et al., 1996) . This vascular injury induces endothelial damage and inflammation, simulating restenosis in humans. All surgical procedures were performed with the mice under general anesthesia (ketamine/xylazine) and analgesia (Buprenorphine).
Streptococcus mutans Infection
Beginning at 14 wks of age, mice in Groups I and II were infected intravenously (via tail vein) once a week for either 6, 12, or 18 wks with strain OMZ175 (10 7 bacterial cells/mouse in 10 μL) ( Fig. 1A) . Control mice were sham-infected. One week after the last intravenous infection, 3-5 mice from each group were euthanized, and the aortas, hearts, spleens, and blood were collected for analysis.
Antibody Analysis
Serum from mice infected with S. mutans was used to determine immunoglobulin G (IgG), IgM, IgA, and IgG subclass antibody concentrations according to a standard ELISA protocol (Verma et al., 2010) .
Detection of Genomic DnA from Aorta, heart, and spleen DNA was isolated from aorta, heart, and spleen samples with the use of the EPICENTRE Master Pure DNA Purification Kit (EPICENTRE, Madison, WI, USA) with modifications, and PCR was performed (Appendix).
histology Hematoxylin-eosin-stained (H&E) sections of the aortic arch, thoracic aorta, and abdominal aorta were used for morphometric analysis. Plaque area was measured and the extent of atherosclerosis in the aortic sections of the mice was determined as previously described (Liu et al., 2000 (Liu et al., , 2004 . The mean total cross-sectional intimal area or the mean intimal thickness normalized to medial thickness was calculated for each arterial section and used for statistical analyses. (For detailed methods, see the Appendix.)
Immunohistochemistry
Mouse aortic specimens were also assessed by immunohistochemical staining for the presence of macrophage and TLR4 expression and compared with smooth-muscle cells to assess inflammatory cell responses as previously described (Liu et al., 2000 (Liu et al., , 2004 .
statistical Analysis
Values are expressed as mean ± standard error (SE). An unpaired, two-tailed Student's t test was used to compare groups of animals. Differences with p values less than 0.05 were considered statistically significant. Histological measurements were analyzed by analysis of variance (ANOVA) with the Statview program as described previously (Liu et al., 2000) with post hoc PLSD analysis. The antibody data are presented as means ± standard deviation (SD) (Prism 4, GraphPad software), with P values calculated by the Kruskal-Walis ANOVA with Dunn's correction for multiple comparisons and the Mann-Whitney Student t test.
rEsults Antibody response to S. mutans S. mutans infection (+/-BA) induced approximately a 10,000-fold increase in IgM antibody and significant IgG antibody responses at 6, 12, and 18 wks compared with sham-infected control mice, indicating S. mutans exposure (Figs. 1B, IC).
Detection of Genomic DnA from Aorta, heart, and spleen
Portions of the hearts, aortas, and spleens were examined for the presence of S. mutans genomic DNA by PCR. The PCR results (Table) demonstrated that amplicons for S. mutans were present in DNA isolated from the liver (9/10), heart (2/10), and thoracic aorta (6/10) from the Sm group. S. mutans was also detected in the liver (10/10), spleen (2/10), heart (2/10), and abdominal aorta (10/10) from Sm+BA mice. Combined analysis of all aortic specimens in mice with Sm+BA demonstrated a significant increase in plaque area (3×) (p < 0.05) when compared with BA with sham infection (Fig.  2A) . The aortic plaques of the Sm group at 18 wks were larger than those of the corresponding control mice, but this difference, although demonstrating a clear trend, was not significant ( Fig. 2A) . With respect to the intimal/medial thickness, the plaques of the Sm mice were also larger than those of non-infected mice, but this again did not reach significance, whereas the Sm+BA mice had significantly increased (p < 0.05) intimal to medial thickness ratios when compared with control mice (Fig. 2B) . Thus, S. mutans OMZ175 induced an increased plaque size, measured either as plaque area or intimal-to-medial-thickness ratios in BA-treated mice. In addition, there was a trend toward increased plaque size with S. mutans and no BA.
The aortic sections were also assessed for vessel wall and lumen area as well as invading mononuclear cell count. As can be seen in Figs. 2C and 2E , the largest plaques were evident in S. mutans-infected groups. Histological sections of plaque growth in these infected groups demonstrated large plaques with embedded cholesterol crystals and invading inflammatory cells in all arterial layers, with associated loss of lumen area (Fig. 2E) . In contrast, minimal plaques and no cholesterol crystals were visible in sections from the matched sham-infected control mice (Figs.  2D, 2F) .
With respect to earlier times, there was a gradual increase in plaque size from 6 to 18 wks after BA with S. mutans infection, and with BA alone there was a gradual increase from the early time (6 wks) to late (18 wks) follow-ups. This increase over time was most marked for the thoracic aorta but was also seen in the abdominal aorta (data not shown).
Immunohistochemistry of Macrophage Infiltration
Recruited macrophages in atherosclerotic lesions are known to drive the pathophysiology of atherosclerosis. Immunohistochemistry of mouse abdominal aorta sections demonstrated a significant (p < 0.05) increase in invasion of macrophages in the adventitial area after 18 wks of both Sm+BA (Figs. 3A, 3B) , Sm (Fig. 3C) , and BA alone ( Fig. 3D ) (Lucas et al., 1996; Liu et al., 2004) .
Immunohistochemistry of tlr4
TLR4 is an initiator of cellular activation and inflammation, and its expression exerts an overall pro-atherogenic effect by promoting lipid and leukocyte accumulation within lesions. In our study, significant up-regulation of TLR4 expression (p < 0.05) occurred after 18 wks of S. mutans infection and BA vascular injury in the adventitial layers of abdominal aortic sections from the mice (Figs. 3E, 3F ) when compared with S. mutans alone (Fig. 3G ) and control mice (Fig. 3H ).
DIscussIOn
It is without dispute that S. mutans reaches cardiovascular tissues in humans. S. mutans is an etiologic agent of both bacteremia and infective endocarditis (IE) (Drangsholt, 1998; Li et al., 2000; Nakano et al., 2007b) . The endothelium forms a continuous cellular sheet or organ interconnecting the heart, valves, and arterial linings. Thus, the direct interactions between oral bacteria and endothelial cells of the valves and arteries could have a significant effect on the progression of both valvular disease and atherosclerosis.
A pathogen's ability to attach to and invade aortic endothelial cells in vitro and vascular tissues in vivo has previously been shown to be required for virulence in an animal model of atherosclerosis (Li et al., 2002; Gibson et al., 2004) . The present study establishes an animal model for investigation of the pathogenesis of a chronic systemic infection and subsequent atherosclerosis by an invasive S. mutans strain. The results indicate that S. mutans OMZ175 produces significant pathology, including enhanced plaque and increased inflammatory responses when compared with control mice. This study establishes that infection with an invasive strain of S. mutans accelerates atherosclerotic plaque development and inflammatory cell invasion in this mouse model, with greatest increases when there is concomitant endothelial BA injury.
Our results may initially appear to be contradictory to those published recently by Zhang et al. (2010) , who, also using the ApoE null mouse model (but no BA), reported that S. mutans did not increase atherosclerotic plaque growth. The results demonstrated that atherosclerotic plaques in infected mice were virtually identical to those in the PBS control mice, whereas our results demonstrated significantly increased plaque size and area in mice with BA and demonstrated a trend toward increased plaque even without BA. Most significantly, Zhang et al. (2010) used S. mutans strain GS-5, a strain that we have previously reported cannot invade HCAECs. Thus, the results from Zhang et al. (2010) are consistent with and provide additional support for the hypothesis that only invasive S. mutans strains are associated with atherosclerotic pathology.
Interestingly, the pattern of detection of S. mutans DNA in tissues was different in mice subjected to BA compared with those exposed to S. mutans alone. In both cases, S. mutans genomic DNA was detected in the liver of almost all mice and in the hearts of 2 in each group. However, S. mutans genomic DNA was detected in the thoracic aortas in 6 out of 10 mice in the Sm group, but in none of the Sm+BA group. In contrast, S. mutans DNA was found in the abdominal aortas of all mice in the Sm+BA group, but in none of the abdominal aortas of the Sm group. The presence of genomic DNA in these tissues is suggestive, although not proof, of the presence of live bacteria. However, the presence of S. mutans genomic DNA in the abdominal aortas of Sm+BA mice corresponds to the induction of plaque and inflammation in these mice.
TLRs are a class of proteins that play a critical role in the activation of innate immunity by recognizing pathogenic invaders and are highly expressed in atherosclerotic tissues (Michelsen et al., 2004) . Several in vivo studies have reported that another oral pathogen, P. gingivalis, was also found to accelerate atherosclerosis in ApoE -/mice (Gibson et al., 2004) , and infection correlated with increased expression of the innate immune response markers, TLR-2 and TLR-4 (Liu et al., 2008) . Analysis of our data with S. mutans clearly demonstrated increased atherosclerotic plaque concomitant with the expression of TLR4 in aortic tissue.
Restenosis, one particular form of atherosclerosis after BA with stent implants in humans, results in recurrent blockage of arterial sites in 30% to 50% of patients (Counsell et al., 2004) . This percutaneous intervention damages the endothelium and underlying smooth-muscle cells, exposing highly inflammatory and thrombotic connective tissue proteins such as collagen and glycosaminoglycans as well as lipid deposits (Liu et al., 2000) . Analysis of the data indicates that BA significantly increases the interactions between S. mutans and the vasculature, suggesting that BA makes available additional receptors/tissues that allow for enhanced interactions between S. mutans OMZ175 and the 
